NO20025473L - Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav - Google Patents

Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav

Info

Publication number
NO20025473L
NO20025473L NO20025473A NO20025473A NO20025473L NO 20025473 L NO20025473 L NO 20025473L NO 20025473 A NO20025473 A NO 20025473A NO 20025473 A NO20025473 A NO 20025473A NO 20025473 L NO20025473 L NO 20025473L
Authority
NO
Norway
Prior art keywords
products suitable
lymphocytes
preparation
selective labeling
radiopharmaceutical products
Prior art date
Application number
NO20025473A
Other languages
English (en)
Other versions
NO20025473D0 (no
Inventor
Roberto Pasqualini
Emmanuel Bellande
Nicolas Noiret
Alain Roucoux
Henri Patin
Franck Mevellec
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20025473D0 publication Critical patent/NO20025473D0/no
Publication of NO20025473L publication Critical patent/NO20025473L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20025473A 2000-05-23 2002-11-15 Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav NO20025473L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0006549A FR2809401B1 (fr) 2000-05-23 2000-05-23 Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation
US09/584,108 US6469146B1 (en) 2000-05-23 2000-05-31 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
PCT/IB2001/000825 WO2001090114A1 (en) 2000-05-23 2001-05-14 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation

Publications (2)

Publication Number Publication Date
NO20025473D0 NO20025473D0 (no) 2002-11-15
NO20025473L true NO20025473L (no) 2003-01-21

Family

ID=26212417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025473A NO20025473L (no) 2000-05-23 2002-11-15 Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav

Country Status (13)

Country Link
US (1) US6469146B1 (no)
EP (1) EP1283842B1 (no)
JP (1) JP2003534348A (no)
AT (1) ATE256690T1 (no)
AU (1) AU2001260519A1 (no)
DE (1) DE60101574T2 (no)
DK (1) DK1283842T3 (no)
ES (1) ES2213115T3 (no)
FR (1) FR2809401B1 (no)
NO (1) NO20025473L (no)
PT (1) PT1283842E (no)
TR (1) TR200400533T4 (no)
WO (1) WO2001090114A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832408B1 (fr) * 2001-11-20 2005-07-15 Schering Ag Complexes de technetium ou de rhenium, produits radiopharmaceutiques les contenant et leur preparation
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
FR2956325B1 (fr) 2010-02-18 2013-03-15 Enscr Radiomarquage stable a dose therapeurique au rhenium-188, et automatisation de celui-ci, en particulier pour le traitement du cancer du foie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698272B1 (fr) 1992-11-20 1994-12-30 Cis Bio Int Procédé de marquage cellulaire au moyen de complexes nitruro-bis (dithiocarbamato)Tc-99m et trousse pour la mise en Óoeuvre de ce procédé.

Also Published As

Publication number Publication date
TR200400533T4 (tr) 2004-04-21
DE60101574D1 (de) 2004-01-29
US6469146B1 (en) 2002-10-22
EP1283842B1 (en) 2003-12-17
ATE256690T1 (de) 2004-01-15
JP2003534348A (ja) 2003-11-18
AU2001260519A1 (en) 2001-12-03
EP1283842A1 (en) 2003-02-19
PT1283842E (pt) 2004-04-30
WO2001090114A1 (en) 2001-11-29
NO20025473D0 (no) 2002-11-15
FR2809401A1 (fr) 2001-11-30
ES2213115T3 (es) 2004-08-16
DK1283842T3 (da) 2004-04-13
DE60101574T2 (de) 2004-09-16
FR2809401B1 (fr) 2004-01-02

Similar Documents

Publication Publication Date Title
FR2848850B1 (fr) Nouvelles compositions de particules magnetiques recouvertes de derives gem-bisphosphonates.
ATE214055T1 (de) Retinoid-potenzierende verbindungen
NO307568B1 (no) Forbindelse egnet for radiomerking, kit for fremstilling av et radiofarmasøytikum samt dette farmasøytikum, direkte radiomerket forbindelse og radiofarmasøytisk preparat
DE3378052D1 (en) Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
BRPI0413991A (pt) composto ativador de ppar e composição farmacêutica contendo o mesmo
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
ES2060002T3 (es) Compuestos formadores de quelatos para la complejacion de isotopos radiactivos, sus complejos con metales, asi como su utilizacion en diagnostico y terapia.
ES2106142T3 (es) Composiciones detergentes.
NL181004C (nl) Parfumcomposities alsmede geparfumeerde produkten, welke ten minste een acylpolyalkylindanverbinding als reukstof bevatten, alsook de toegepaste acylpolyalkylindanverbindingen.
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
DE69710395D1 (de) PH-empfindliche Mikrokapseln.
ES2243579T3 (es) Derivados de pirazolopirideno.
BE879263A (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
EP1104761A4 (en) FLUORESCENT MARKERS
NO20025473L (no) Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav
WO1998014220A3 (en) Technetium-99m labeled chelator incorporated cyclic peptides
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
LU84491A1 (fr) Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3
NO20043211L (no) Imidazo [1,2-a]pyridinderivat
AR012990A1 (es) Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa.
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
ES2069669T3 (es) Compuestos biocidas.
EP0978277A4 (en) ANTI-RHUMATISMAL AGENTS
DE502004009136D1 (de) NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
MXPA05013328A (es) Preparaciones que contienen por lo menos un hidroformiato.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application